Delivery Order SPE2DB20D2104-SPE2DB25FNAFC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- AmerisourceBergen Drug Corp was awarded a $2,385.30 delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $9,133.43 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Candesartan Cilexetil 8 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations facility. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.86 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order is...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count units) with a ceiling value of $2,812.08. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $3,511.93. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Candesartan Cilexetil 32 mg tablets in a quantity of 90 units, with a ceiling value of $9,664.09. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was awarded on September 10, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $3,867.24 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAFCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $1,425.93. This firm fixed-price delivery order, which is expected to be completed by September 12, 2025, represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order leverages AmerisourceBergen Drug Corp's $999,999,999 IDC with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical supply vehicle for military healthcare systems and federal medical procurement needs. AmerisourceBergen's role as a prime pharmaceutical vendor enables it to fulfill critical medication requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting history and demonstrated capability in managing large-volume pharmaceutical deliveries position it as a key supplier within the federal medical supply chain for defense-related healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/11/25 |